The Pharmaceutical Sector 2016-2020 – USA Dominates, But China Potential Is Huge!

With a population of 324M (4.4% of the world) and an average per capita spend of $1,050, the USA dominates the global pharmaceutical market at $340B spend with a third of global sales ($1,072B).

In comparison, China, with four times the population of the USA at 1.38B (18.6% of the global population), has only $125.6B spend, 12% of global sales. The average per capita spend in the USA is $1,050 compared to China’s $91, leaving huge scope for growth as China’s population develops in class and earnings.

If China reached USA levels of per capita spend, the China market could be worth a staggering $1,450B, more than the present spend worldwide! However, the present (2016) Chinese average annual salary of RMB62k is the equivalent of $9k, and only projected to rise to RMB90k ($13k) by 2020. This could increase the average per capita spend from $91 to $133. Combined with the population projection of 1.4B (low growth), this would result in a market worth approximately $186B in 2020, catching up with the USA, but still around half the value.

For questions or any other enquiries please contact us here.

Alternatively, click here to read our latest blog.